Market revenue in 2023 | USD 192.2 million |
Market revenue in 2030 | USD 286.6 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Biomarker services |
Fastest growing segment | Genetic Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.45% in 2023. Horizon Databook has segmented the Germany central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
Germany holds a significant share of Europe's central lab market, primarily due to its large geriatric population.
In 2020, 18.27 million people in Germany were aged over 65, accounting for 22% of the population. This high concentration of the geriatric population in the country leads to high growth opportunities for central lab services for studies related to chronic diseases.
The reimbursement scenario is also lenient in the country due to increased prices by manufacturers. The German Health Technology Assessment in coordination with the Institute for Quality and Efficiency in Health Care (IQWiG) regulates reimbursement in Germany by levying average prices for the same tests for different individuals.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany central lab market , including forecasts for subscribers. This country databook contains high-level insights into Germany central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account